IMMUNOACTIVATOR, VACCINE ADJUVANT, AND METHOD FOR INDUCING IMMUNITY

WIPO Patent Application WO/2023/210722

A1

In order to provide an immunoactivator capable of enhancing both humoral immunity and cellular immunity, the active ingredient of the immunoactivator being derived from cell walls (derived from a natural product), to provide a vaccine adjuvant, and to provide a method for inducing immunity, the method having a step for administering the immunoactivator, an immunoactivator according to the present invention has particles having a maximum diameter within the range of 1-800 nm as the active ingredient, the particles being composed of cell-wall-derived polysaccharides.

SUZUKI RYO (JP)
OMATA DAIKI (JP)
MUNAKATA LISA (JP)
SUZUKI YUNO (JP)
KOIZUMI KEIICHI (JP)

PCT/JP2023/016572

November 02, 2023

April 27, 2023

Click for automatic bibliography generation  

UNIV TEIKYO (JP)

A61K39/39; A61K31/715; A61K36/06; A61K36/484; A61P31/00; A61P35/00; A61P37/04

WO2019156174A1	2019-08-15
WO2018062343A1	2018-04-05
WO2021141025A1	2021-07-15

CN113143977A	2021-07-23
CN112426524A	2021-03-02
JP2015129114A	2015-07-16

YUNO SUZUKI, RISA MUNAKATA, DAIKI OMATA, KEIICHI KOIZUMI, RYO SUZUKI: "Assessment of the activity as immuno-stimulator of the nanoparticles derived from glycyrrhiza and its feasibility study as vaccine adjuvant", ABSTRACTS OF THE 142ND ANNUAL MEETING OF PHARMACEUTICAL SOCIETY OF JAPAN; MARCH 25, 2022 - MARCH 28, 2022, PHARMACEUTICAL SOCIETY OF JAPAN, JP, vol. 142, 4 March 2022 (2022-03-04) - 28 March 2022 (2022-03-28), JP, pages 28F - pm16S, XP009550536

SAITOH Yukihiko et al. (JP)

View/Download PDF      PDF Help

Previous Patent: POINTER DEVICE AND INPUT DEVICE

Next Patent: THERAPEUTIC PHARMACEUTICAL COMPOSITION INTENDED TO ACT IN INTESTINE